Misremembered Flashcards

1
Q

Site of ANTERIOR EPISTAXIS

A

KIESSELBACK PLEXUS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Site of POSTERIOR EPISTAXIS

A

WOODRUFF PLEXUS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

DISCHARGE MEDICATIONS AFTER CAUTERISATION

A

NASEPTIN (PEANUT OIL)
BACTROBAN (IF NUT ALLERGY)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

SIGN CRITERIA FOR TONSILLECTOMY

A

o 7+ IN ONE YEAR
o 5+/YEAR FOR 2 YEARS
o 3+/YEAR FOR 3 YEARS
o 2+ PERITONSILLAR ABSCESS EVER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MOST COMMON TYPE OF THYROID CANCER + BUZZWORDS

A

PAPILLARY CARCINOMA (ORPHAN ANNIE NUCLEI + PSAMMOMA BODIES)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

BERRY’S SIGN

A

LACK OF CAROTID PULSE DUE TO MALIGNANT THYROMEGALY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  • SWELLING AROUND SALIVARY GLAND AND FACIAL WEAKNESS
A

PLEIMORPHIC ADENOMA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pott’s disease

A

vertebral bodies (Pott’s disease) - tb infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

If pharmacological cardioversion has been agreed on clinical and resource grounds for new-onset atrial fibrillation, offer

A
  • flecainide or amiodarone if there is no evidence of structural or ischaemic heart disease or
  • amiodarone if there is evidence of structural heart disease.’
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

MALARIA PREVENTION

A

· Anti-malarial prophylaxis with quinine
· Bite prevention – repellent and nets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

WHEN TO ADMIT FOR MALARIA?

A

severe/complicated malaria, falciparum malaria, child, pregnant, ≥65yo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

TREATMENT OF NON-FALCIPARUM

A

1st line = chloroquinine or ACT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

TX OF MILD FALCIPARUM

A

(= not vomiting, parasitaemia <2% and ambulant):
* 1st line = ACT (Artemisinin Combination Therapy)
* 2nd line = atovaquone-proguanil or quinine + doxycycline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

TX OF SEVERE FALCIPARUM

A

1st line = IV artesunate
2nd line = IV quinine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

EXTRA TX FOR PLASMODIUM VIVAX AND OVALE

A

Primaquine (not G6PDD): hypnozoites eradication (dormant parasites in liver in vivax / ovale)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

HOW MUCH FLUID TO GIVE SOMEONE WITH SEVERE BURNS

A

PARKLAND FORMULA – VOLUME OF FLUID = TOTAL BODY SURFACE AREA OF BURN % X WEIGHT (KG). HALF OF THIS FLUID TO BE ADMINISTERED IN FIRST 8 HOURS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

CRITERIA FOR BURNS UNIT

A
  • Complex burns, burns involving the hand perineum and face and burns >10% in adults and >5% in children should be transferred to a burns unit.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

ESCHAROTOMIES DEFINITION

A

circumferential full thickness burns to the torso or limbs. Careful division of the encasing band of burn tissue will potentially improve ventilation (if the burn involves the torso), or relieve compartment syndrome and oedema (where a limb is involved)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

MUCOSAL INVOLVEMENT IN BULLAE SKIN

A
  • Mucosal involvement in blister: MUCOSAL INVOLVEMENT = PEMPHIGUS VULGARIS, NOT = BULLOUS PEMPHIGOID
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

WHEN TO OFFER PLT INFUSION IN SIGNIFICANT BLEEDING?

A

OFFER IF PLT COUNT < 30 X 10^9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

WHEN TO OFFER PLT INFUSION IN SEVERE BLEEDING?

A

OFFER IF PLT COUNT < 100 X 10^9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

PLT LEVEL AIMS IN SURGERY

A

IF BEFORE SURGERY AIM FOR > 50 X 10^9.
50-75 X 10^9 FOR HIGH RISK OF BLEEDING.
>100 x 10^9 FOR SURGERY AT CRITICAL SITE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

WHEN TO OFFER PLT INFUSION IF NO BLEEDING? CONTRAINDICATIONS?

A

OFFER IF < 10 X 10^9 UNLESS CI: CHRONIC BM FAILURE, AI THROMBOCYTOPENIA, HEPARIN INDUCED THROMBOCYTOPENIA OR TTP.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

LESIONS IN HORNERS SYNDROME?

A

o CENTRAL LESION (ANHYDROSIS OF FACE, LIMBS AND TRUNK)
o PRE-GANGLIONIC (ANHYDROSIS OF FACE)
o POST-GANGLIONIC (NO ANHYDROSIS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

CENTRAL LESIONS LEADING TO HORNERS

A

 STROKE
 SYRINGOMYELIA
 SCLEROSIS (MS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

PRE-GANGLIONIC LESIONS LEADING TO HORNERS

A

 TRAUMA
 TUMOUR (PANCOAST)
 THYROIDECTOMY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

POST-GANGLIONIC LESIONS LEADING TO HORNERS

A

 CLUSTER HEADACHES
 CAROTID ARTERY DISSECTION
 CAROTID ANEURYSM
 CAVERNOUS SINUS THROMBOSIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

MOST COMMON CAUSE OF CELLULITIS

A

o STREP PYOGENES MOST COMMONLY BUT ALSO STAPH AUREUS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

MOST COMMON CAUSE OF RHEUMATIC FEVER

A

STEP PYOGENES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q
  • CAUSES OF INFECTIVE ENDOCARDITIS
A

o MOST COMMONLY (SPECIALLY IVDU) – STAPH AUREUS
o OTHER : STEP VIRIDANS (USED TO BE MOST COMMON, NOW ONLY DEVELOPING COUNTRIES)
o STAPH EPIDERMIDIS – PROSTHETIC VALVE SURGERY
o STREP BOVIS – COLORECTAL CANCER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q
  • ERON CLASSIFICATION
A

FOR CELLULITIS
o I – NO SIGN OF SYSTEMIC TOXICITY
o II – EITHER SYSTEMICALLY UNWELL OR SYSTEMICALLY WELL BUT HAS A COMORBIDITY THAT COULD PUT HIM AT RISK OF LENGTHENED RESOLUTION OF INFECTION (PAD, CHRONIC VENOUS INSUFFICIENCY, MORBIDY OBESITY)
o III – SIGNIFICANT SYSTEMIC UPSET (E.G. ACUTE CONFUSION, TACHYCARDIA, TACHYPNOEA, HYPOTENSION) OR UNSTABLE COMORBIDITIES THAT MAY INTERFERENCE WITH REPONSE TO TX.
o IV – SEPTIC OR SEVERE LIFE-THREATENING INFECTION (NECROTIZING FASCIITIS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

WHEN TO ADMIT FOR IV ABX FOR CELLULITIS?

A

 CLASS III AND IV
 FRAIL OR VERY YOUNG(<1YR)
 IMMUNOCOMPROMISED
 RECENT LYMPHOEDEMA
 RAPIDLY DETERIORATING CELLULITIS
 FACIAL OR PERIORBITAL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

MX OF CLASS I CELLULITIS

A

ORAL ABS (FLUCLOXACILLIN) IF ALLERGIC TO PENICILLIN: CLARITHROMYCIN OR DOXY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

MX OF CLASS II CELLULITIS

A

NO NEED FOR ADMISSION IF IV ABX CAN BE GIVEN IN COMMUNITY AND MONITORING

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

AAA TYPES AND MANAGEMENT

A
  • AAA 3-4.4 cm = another USS in a year
  • AAA 4.5-5.4 = follow up in 3 months and conservative/medical management (statins, aspirin, HTN management. Stop smoking, WL)
  • AAA >5.5 =Surgical – open aortic surgery or EVAR (endovascular aortic repair)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

INDICATIONS FOR SURGERY AAA

A

Ruptured, symptomatic, >5.5 cm and > 4cm and grown more than >1 cm in 1 year.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

MEDICAL MX FOR ACUTE LIMB ISCHAEMIA

A

o PROLONGED COURSE OF HEPARIN
o IV HEPARIN (REPEATED APTT)
o 02

38
Q

SURGICAL MX FOR ACUTE LIMB ISCHAEMIA

A

o EMBOLUS
 EMBOLECTOMY
 THROMBOLYSIS
 BYPASS
o THROMBUS
 THROMBOLYSIS
 ANGIOPLASTY
 BYPASS

39
Q

VARICOSE VEIN MX

A
40
Q

MX OF GANGRENE

A

o ABX, SURGICAL DEBRIDEMENT, MAGGOT DEBRIDMENET, HYPERBARIC OXYGEN, VASCULAR SURGERY

41
Q

MEDICAL MX OF PAD

A

o TREAT COMORBIDITIES – HTN, DM, OBESITY
o STATIN AND CLOPIDOGREL.

42
Q

OTOSCLEROSIS DEFINITION

A

REPLACEMENT OF NORMAL BONE BY VASCULAR SPONGY BONE  PROGRESSIVE CONDUCTIVE DEAFNESS. AUTOSOMAL DOMINANT

43
Q

ALZHEIMERS PATHOHYSIOLOGY

A

MACROSOPICALLY – CORTICAL + HIPPOCAMPAL ATROPHY. MICROSCOPICALLY – TAU PROTEIN AND TYPE A BETA AMYLOID

44
Q

ALZHEIMERS MX

A

o NON PHARM: ACTIVITIES TO PROMOTE WELLBEING, COGNITIVE STIMULATION THERAPY, GROUP REMINISCENCE THERAPY
o PHARM: MILD – MOD – ACH ESTERASE INHIBITOR – DONEPEZIL, GALANTAMINE, RIVASTIGMINE. SEV – NMDA RECEPTOR ANTAGONIST (MEMANTINE) – ALSO USED IF FIRST ONE CI’ED OR CAN BE ADDED ON TO ACH INHIBITOR

45
Q
  • CI AND AE OF DONEPEZIL:
A

CI – BRADYCARDIA. AE – INSOMNIA.

46
Q

S/S OF REACTIVE ARTHRITIS

A
  • REACTIVE ARTHRITIS – “CANT SEE PEE OR CLIMB A TREE”
    o WITHIN 4 WEEKS OF INFECTIONS – SYMPTOMS ONSET
    o OLIGOARTHRITIS
    o URETHRITIS
    o CONJUCTIVITIS OR ANTERIOR UVEITIS
    o SKIN – KERATODERMA BLENORRHAGICA
47
Q

CAUSES OF REA

A

POST-STI (CHLAMYDIA) OR POST DYSENTERIC (SHIFELLA, SALMONELLA, YERSINIA, CAMPYLOBACTER)

48
Q

MX OF REA

A

SYMPTOMATIC: ANALAGESIA, NSAIDS, INTRARTICULAR STEROIDS. SULFASALAZINE OR MTX FOR PERISTENT DISEASE. CAN LAST FOR 4-6 MONTHS

49
Q

CAUSES OF URETHRITIS IN MALES

A

GONORRHOEA, CHLAMYDIA, MYOCPLASMA GENITALUM

50
Q

MX OF INTRADUCTAL PAPILLOMA

A

microdochectomy

51
Q

PHYLLODES TUMOUR BIOPSY

A

enlarging mass, mixed epithelial and connective tissue elements

52
Q

mammogram shows an area of focal microcalcification

A

DCIS

53
Q

Biopsy demonstrates a biphasic lesion characterised by stromal and epithelial elements.

A

FIBROADENOMA

54
Q

DUCT ECTASIA SX

A

dilation of the duct  tender lump around areola +/- green/cheesy nipple discharge +/- periductal mastitis

55
Q

DUCT ECTASIA MX

A

Young  microdochectomy. Old  total duct excision

56
Q

NOTTINGAM PROGNOSTIC SCORE

A

tumour size x 0.2 + LN score + grade score

57
Q

OSTEOMYELITIS TYPES

A

o Heamatogenous – from bacteraemia, most common in children, vertebral osteromyelitis in adults, RF: IV drug use, SCA, immunosuppression, infective endocarditis
o Non-haematogenous – from adjacent tissue or from direct injurt to the bone, most common form in adult, RFs: DM, diabetic foot ulcers/pressure sores, PAD.

58
Q

CAUSATIVE ORGANISM OF OSTEOMYELITIS

A

staph aureus but SCA – salmonella

59
Q

IX FOR OSTEOMYELITIS

A

MRI

60
Q

MX OSTEOMYELITIS

A

Flucloxacillin for 6 weeks. Clindamycin if allergy

61
Q

KLEBSIELLA PNEUMO MX

A

cephalosporin (e.g. cefotaxime)

62
Q
  • Legionella pneumo mx
A

: clarithromycin

63
Q

APML

A

fusion of PML and RAR-alpha genese. Aier rods. Dic or thrombocytopenia at presentation.

64
Q

AML TX

A
  • supportive (RBC, Plts, FFP/croprecipitate, Abx) Chemo, targeted molecular therapy (APML = all-trans-retinoic acid/ATRA and A203), transplantation – allogenic SCT
65
Q

ALL TX

A

supportive, Chemo, Molecular therapy (imatinib for Ph+ve cases. Rituximab mAb against CD20)

66
Q

CML

A

associated with Philadelphia chromosome (9+22), splenomegaly, hepatomegaly

67
Q

CML TX

A

associated with Philadelphia chromosome (9+22), splenomegaly, hepatomegaly

68
Q

COMMONEST LEUKAEMIA IN WESTERN

A

CLL

69
Q

SX OF LEUKAEMIA

A

often none. Can have WL, anorexia, bleeding, infections. Smear cells

70
Q

BIGNET

A

CLL STAGING
 A – high WCC, <3 groups of enlarge LNs  no tx required
 B - >3 groups of enlarged LNs
 C – Anaemia and thrombocytopenia

71
Q

RICHTER TRANSFORMATION

A

o Leukemia cells enter LNs and change into high grade NHL
o Sx: LN swelling, fever, WL, Night sweats, Nause, abdo pain

72
Q

CLL TX

A

o Supportive – vaccination, infective prophylaxis, IVIG
o No chemo-incurable by chemo
 Chemi immunotherapy  Rituximab, cyclophosphamide, ibrutinib, venetoclav, Car-T
o Young patient – allogeneic stem cell transplantation.

73
Q
  • T2DM tx licensed in CKD
A

– DPP4i

74
Q
  • Cataplexy
A

classically presents with loss of skeletal muscle tone with strong (usually postive) emotions

75
Q
  • Effect of Bendroflumethiazide on sodium
A

Lowers it

76
Q
  • Common STI causing proctitis and lymphadenopathy
A

Lymphogranuloma venereum.

77
Q

Mx of genital warts

A

Topical podophyllum or cryotherapy - 1st line
- multiple, non-keratinised warts warts –> topical agents
- solitary, keratinised warts –> cryptherapy
- 2nd line - imiquimod

78
Q

STAGE I Hypertensive retinopathy

A

Silver wiring - increased light reflex
Arteriolar narrowing and tortuosity

79
Q

STAGE II Hypertensive retinopathy

A

Development of areas of focal narrowing, and compression of venules at sites of arteriovenous crossing (AV nipping).

80
Q

STAGE III Hypertensive retinopathy

A
  • Cotton wool exudates
  • Flame and blot haemorrhages –> may collect around fovea –> macular star
81
Q

STAGE IV Hypertensive retinopathy

A

Papilloedema
optic disc swelling.

82
Q

Stages of diabetic retinopathy

A
  • non-proliferative
    -proliferative
    -maculopathy
83
Q

Types of non proliferative

A

mild - 1 or more microaneurysms
moderate - Microaneurysms + blot haemorrhages + hard exudates + soft exudates
severe (pre-proliferative) - blot haemorrhages. microaneurysms in a 4 quads. venous beading in at least 2. intraretinal microvascular abnormalities in 1 quad.

84
Q

Proliferative diabetic retinopathy

A

Neovascularisation. More typical in Type I

85
Q

Maculopathy

A

More common in type II. Hard exudates and changes on macula.

86
Q

Tx of proliferative diabetic retinopathy

A

Pan-retinal photocoagulation is the primary treatment

87
Q
A

Central retinal artery occlusion presents with sudden, profound loss of vision.

88
Q
A

Central retinal vein occlusion occurs secondary to atherosclerotic thickening of the central retinal artery compressing the central retinal vein at a common crossing point.

89
Q

cocaine overdose management

A

benzodiazepines then nitrates

90
Q

blood supply to legs, buttocks and both.

A

legs - external ileac
buttocks -internal ileac
both - common iliac

91
Q

Gullain Barre mx

A

intravenous immunoglobulin and plasmapheresis